Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tissue Transplantation01:24

Tissue Transplantation

338
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
338

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The Phenotype List String Grammar for Enhanced Protein and Antigen Reporting in the Immunogenetic Context.

HLA·2026
Same author

Evaluation of dnDSA risk stratification using the updated PIRCHE-T2 model in two kidney transplant cohorts.

Frontiers in immunology·2026
Same author

Preformed donor-specific antibodies are associated with acute rejection and biliary complications after liver transplantation: A Swiss Transplant Cohort Study analysis.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same author

An integrative algorithm combining HLA epitope registry, PIRCHE-T2, and PIRCHE-B outcomes to improve immunological risk stratification in kidney transplantation.

Frontiers in immunology·2026
Same author

Molecular Disparity of HY Antigen Affects Chronic Graft-Versus-Host Disease and Relapse in Female-to-Male Stem Cell Transplants.

Transplantation and cellular therapy·2025
Same author

Impact of HLA evolutionary divergence and donor-recipient molecular mismatches on antibody-mediated rejection of kidney allografts.

Nature communications·2025

相关实验视频

Updated: Jun 4, 2025

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

10.0K

分子匹配工具用于分配和免疫抑制优化. 准备好进入黄金时段吗?

Matthias Niemann1,2, Benedict M Matern1,3

  • 1PIRCHE AG.

Current opinion in organ transplantation
|December 23, 2024
PubMed
概括

器官移植中的分子匹配显示出改善患者结果和风险分层的前景. 目前正在进行的研究重点是改进算法,并将这些发现应用于器官分配和个性化免疫抑制策略.

科学领域:

  • 器官移植免疫学 器官移植免疫学
  • 移植中的生物信息学
  • 临床结果研究研究的临床结果.

背景情况:

  • 在器官移植中,分子匹配至关重要,研究将不兼容性与临床结果联系起来.
  • 分子匹配的临床实用性和应用背景仍在争论中.
  • 关于在临床决策中实施分子匹配,没有普遍的共识.

研究的目的:

  • 审查最近在器官移植分子匹配方面的进展.
  • 探索分子匹配的实际应用和临床实用性.
  • 讨论分子匹配在风险分层和个性化医学中的作用.

主要方法:

  • 关于器官移植中的分子匹配的最新文献的综述.
  • 对算法管道改进的分析.
  • 对不同移植类型和患者队伍的临床证据的评估.

主要成果:

  • 分子匹配的算法管道已经得到了改进,提高了稳定性.
  • 支持分子匹配的临床证据已经扩展到肝脏和肺部移植.
  • 已故器官分配和个性化免疫抑制策略的应用正在出现.

结论:

更多相关视频

Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

6.9K
Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
11:00

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Published on: March 25, 2020

17.0K

相关实验视频

Last Updated: Jun 4, 2025

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

10.0K
Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

6.9K
Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
11:00

Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment

Published on: March 25, 2020

17.0K
  • 分子匹配算法显著提高了移植受体的免疫风险分层.
  • 早期研究正在探索将分子匹配见解转化为临床实践,包括器官分配和个性化医学.
  • 需要进一步的研究和支持,才能将分子匹配完全纳入患者管理.